Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$76.4 - $96.33 $7.65 Million - $9.64 Million
-100,102 Reduced 60.52%
65,291 $6.16 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $2.41 Million - $3.45 Million
40,563 Added 32.49%
165,393 $13.1 Million
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $8.64 Million - $9.87 Million
124,830 New
124,830 $9.39 Million
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $6.72 Million - $9.51 Million
-164,648 Reduced 96.97%
5,139 $224,000
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $2.24 Million - $2.8 Million
47,838 Added 39.23%
169,787 $9.04 Million
Q2 2022

Aug 15, 2022

BUY
$34.86 - $63.77 $3.32 Million - $6.07 Million
95,235 Added 356.5%
121,949 $5.54 Million
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $6.51 Million - $8.49 Million
-146,770 Reduced 84.6%
26,714 $1.55 Million
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $1.46 Million - $2.06 Million
-36,219 Reduced 17.27%
173,484 $7.71 Million
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $6.76 Million - $12 Million
142,516 Added 212.12%
209,703 $10.1 Million
Q2 2021

Aug 16, 2021

SELL
$73.06 - $97.7 $413,373 - $552,786
-5,658 Reduced 7.77%
67,187 $5.7 Million
Q1 2021

May 17, 2021

BUY
$70.43 - $97.42 $1.24 Million - $1.71 Million
17,551 Added 31.74%
72,845 $6.11 Million
Q4 2020

Feb 16, 2021

BUY
$48.9 - $75.26 $2.7 Million - $4.16 Million
55,294 New
55,294 $4.16 Million
Q2 2020

Aug 14, 2020

SELL
$28.78 - $46.83 $260,056 - $423,155
-9,036 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$25.53 - $70.14 $498,958 - $1.37 Million
-19,544 Reduced 68.38%
9,036 $279,000
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $1.55 Million - $1.88 Million
28,580 New
28,580 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$63.59 - $78.71 $1.07 Million - $1.32 Million
-16,829 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$50.75 - $80.54 $854,071 - $1.36 Million
16,829 New
16,829 $1.32 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.